<DOC>
	<DOCNO>NCT01474369</DOCNO>
	<brief_summary>The purpose study investigate superiority efficacy TAK-438 , daily ( QD ) , placebo patient non-erosive gastroesophageal reflux disease .</brief_summary>
	<brief_title>Efficacy TAK-438 Compared Placebo Treatment Non-Erosive Gastroesophageal Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<criteria>1 . Participants grade N M modify LA classification system confirm endoscopy initiation preobservation period ( VISIT 1 ) . 2 . Participants repeat acid reflux symptom ( heartburn regurgitation ) 2 day one week 3 week initiation initiation preobservation period ( VISIT 1 ) . 3 . Participants severity* moderate high acid reflux symptom ( heartburn regurgitation ) 3 week initiation preobservation period ( VISIT 1 ) * Severity : No symptom , mild ( symptoms present often forget ) , mild ( painful ) , moderate ( rather painful ) , severe ( painful ) severe ( painful enough affect night time sleep daily activity ) 4 . Outpatients ( hospitalization test possible ) 1 . Participants esophagusrelated complication [ Barrett 's esophagus ( 3 cm , LSBE ) , eosinophilic esophagitis , esophageal varix , scleroderma , viral fungal infection , esophageal stenosis , etc . ] , history radiotherapy cryotherapy esophagus , caustic physiochemical trauma ( esophageal sclerotherapy , etc. ) . However , participant Barrett 's esophagus ( le 3 cm , SSBE ) Schatzki 's ring ( mucosal tissue ring around inferior esophageal sphincter ) allow include . 2 . Participants receive surgery treatment affect gastroesophageal reflux ( cardioplasty , dilation esophageal stenosis [ exclude Schatzki 's ring ] , etc . ) , history surgery stomach duodenum ( exclude removal benign polyp endoscopy ) 3 . Participants acute upper gastrointestinal bleeding , gastric ulcer ( mucosal defect associate white coating ) duodenal ulcer ( mucosal defect white coating ) within 30 day initiation preobservation period ( VISIT 1 ) However , participant gastric duodenal erosion allow include . 4 . Participants acute gastritis acute exacerbation chronic gastritis complication 5 . Participants previous current history ZollingerEllison syndrome gastric acid hypersecretion disorder 6 . Participants history chest pain due heart disease chest pain suspect caused heart disease within one year initiation preobservation period ( VISIT 1 )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>